Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
BioMarin Pharmaceuticals
Business Segments
Products & Services
Products & Services
5 metrics
Total revenues
13 segments
Derivatives Designated as Cash Flow Hedging Instruments
1 segments
Revenue
6 segments
Payment received as percentage of net product sales
1 segments
R&D
3 segments
Watchlist
Screener
Filings
Earnings
Charts